Related Experiment Videos
Antibacterial activity of cefcanel
1Department of Microbiology, University of Oslo, Norway.
Chemotherapy
|March 1, 1993
Summary
Cefcanel, a new oral cephalosporin, shows strong activity against common bacteria like E. coli and H. influenzae. However, enterococci and oxidative rods demonstrated resistance to this novel antibiotic.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Cephalosporins are a class of beta-lactam antibiotics widely used for bacterial infections.
- Emerging bacterial resistance necessitates the development of new antimicrobial agents.
- Cefcanel is a novel oral cephalosporin with potential therapeutic applications.
Purpose of the Study:
- To evaluate the in vitro antimicrobial activity of cefcanel.
- To determine the minimum inhibitory concentration (MIC) of cefcanel against various clinical bacterial isolates.
- To compare cefcanel's efficacy with other existing cephalosporins.
Main Methods:
- Determination of minimum inhibitory concentrations (MICs).
- Testing against 182 clinical isolates, including Enterobacteriaceae, Streptococcus, nonfermentative rods, Haemophilus influenzae, and Branhamella catarrhalis.
- Comparative analysis with other cephalosporins.
Main Results:
- Cefcanel exhibited greater activity than other cephalosporins against Escherichia coli, Klebsiella aerogenes, and Proteus mirabilis.
- Most Streptococcus species, except enterococci, were susceptible to cefcanel.
- Haemophilus influenzae and Branhamella catarrhalis showed reasonable susceptibility.
- Nonfermentative rods (oxidative rods) were highly resistant to cefcanel.
Conclusions:
- Cefcanel demonstrates promising in vitro activity against key Gram-negative and Gram-positive pathogens.
- Its efficacy against common Enterobacteriaceae and respiratory pathogens like H. influenzae and B. catarrhalis is notable.
- Resistance observed in enterococci and nonfermentative rods warrants further investigation.